Articles
The end of the BIF boom?
With Biotechnology Innovation Fund and R&D Start grants rolled into the new Commercial Ready, the Australian biotech sector may face a post-BIF bust, writes Michael Vitale. [ + ]
Partner or perish
At a recent conference in Sydney, biotechs and big pharma came together to explore how they should work together. Renate Krelle was there. [ + ]
Access to DNA secrets yields better understanding of genes
A new technique for examining DNA is giving scientists a more detailed picture of which genes have the propensity for activation, offering a new tool for understanding how genes function and possibly for diagnosing disease
[ + ]Growing the Australian science industry
The Science Industry Action Agenda is a joint initiative of Science Industry Australia Inc. (SIA) and the Commonwealth government, aimed at maximising the future growth and development of the science industry in Australia
[ + ]INTERVIEW: The innovation tug-of-war
Dr John Raff tells Graeme O'Neill why Australia's agbiotech industry is struggling. [ + ]
AusBiotech 2004: Stem cell pioneer tells why all's well in Wales
One of the leading lights of international stem cell research will be in Australia next week, as a de facto ambassador for Wales as well as to discuss his research. [ + ]
Scientists find way to clean up the drugs market
Researchers from the University of Cambridge have made a breakthrough by using supercritical carbon dioxide (scCO2) as a reaction medium for the preparation of molecules of interest to the pharmaceutical industry
[ + ]Preheating requirements in HTLC
Preheating of the mobile phase has been shown to be an important parameter in attaining maximum performance in high temperature liquid chromatography (HTLC)
[ + ]Clandestine laboratories
Clandestine drug laboratories present hazards and dangers to the community in all areas across Australia, including urban and rural centres
[ + ]21 CFR 11 compliance
The development and widespread adoption of electronic record-keeping and electronic signatures has created unprecedented security challenges for the maintenance and integrity of batch histories in regulated industries
[ + ]Confusion over gene patents
An Australian Law Reform Commission (ALRC) inquiry has found widespread anxiety and uncertainty about whether genetic patents will stifle research and development in the billion-dollar biotech industry
[ + ]How Myriad's GCAT got out of the bag
The past two decades have produced a plethora of patents for DNA diagnostic tests to determine people's susceptibility to common, life-threatening disorders like cancer, cardiovascular disease, hypertension and neurodegenerative diseases like Alzheimer's disease and motor neuron disease. [ + ]
Grid to speed analysis of genomic heritage
The search for faster genomics analysis has spawned a multi-state biotech grid network built from ordinary Windows PCs, reports David Braue. [ + ]
What not to do: the top 10 patenting mistakes
You've run your experiments, got your results, and you've been mentally spending -- or at least licensing -- the proceeds of your bulging IP portfolio. But that may have been the easy part, writes Renate Krelle. Before you go any further, here's a checklist of some of the most common patenting pitfalls. [ + ]
The end of the pioneer trail
Australia's first ever Cooperative Research Centre is winding up operations. Melissa Trudinger joined its stakeholders for a look back at its successes. [ + ]